Actinium Pharmaceuticals reported $54.37M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Actinium Pharmaceuticals USD 54.37M 6.66M Sep/2025
Amgen USD 29.06B 1.17B Dec/2025
Bioline Rx USD 28.52M 3.34M Sep/2025
Capricor Therapeutics USD 100.95M 23.18M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025